
Renal Cell Carcinoma (RCC) is kidney cancer, which starts in the cells of the kidneys, filtering waste materials and excessive fluids from the blood. RCC is an adult kidney cancer.
Causes
Risk Factors
Advanced RCC is well-treated with target therapies such as tyrosine kinase inhibitors and immunotherapies. Localised tumours or patients not fit for surgery can be managed with Stereotactic Body Radiation Therapy (SBRT) as a non-invasive alternative. Personalised treatment using genetic and biomarker testing will maximise therapy responses and outcomes. Holistic care through multidisciplinary teams involving urologists, oncologists, and nephrologists is available. Thailand has also opened its doors to ongoing research, including clinical trials, RCC treatment improvement options, and success rates.
The medical treatment for Renal Cell Carcinoma (RCC) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Surgery: Two main surgical procedures exist for renal cell carcinoma (RCC): radical nephrectomy, which means excision of the entire kidney, and partial nephrectomy, which consists of tumour excision with some conservation of kidney function. The best outcomes for localised RCC are related to surgery.
Targeted therapy : Agents that inhibit some biological pathways critical for tumour development are generally indicated when the disease is in more advanced stages or surgery has not yet been an option.
Cost Start From USD 3500Explore Options
Immunotherapy : Checkpoint inhibitors enhance the immune response against the tumour cells so that they may be indicated for advanced or metastatic RCC, usually combined with targeted therapy.
Cost Start From USD 3000 - USD 13578Explore Options
Radiation therapy: Radiation helps shrink tumours, palliate symptoms like pain, or treat other organ metastases such as bone or lung. It is not a first-line treatment but can also be employed for pain management.
Ablation and chemotherapy : Ablation therapies, such as RFA or cryoablation, may be done for small tumours as minimally invasive procedures in patients unfit for surgery. Chemotherapy is not commonly used in renal cell carcinoma but may apply in certain histologic types or after other treatments have failed.
Cost Start From USD 1000 - USD 6800Explore Options
These are the standard diagnostic methods for diagnosing Renal Cell Carcinoma (RCC):
Imaging Studies
Biopsy
Urine and Blood Tests
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Renal Cell Carcinoma (RCC), a targeted therapy-dependent malignancy, can block cancer growth pathways, and immunotherapies can boost the immune system's capability to fight cancer. Chemotherapy is not so much a treatment option for RCC. Therapy is determined, mainly focusing on cancer stage, rate of progression, and patient response to prior treatment.









Bangkok, Thailand
Bangkok Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the growing reasons for India being frequented for Renal Cell Carcinoma (RCC) treatment:
If detected early and treated surgically, RCC is curable, whereas treatment of late or metastatic RCC is much more difficult since a cure may not always be achieved; therefore, the main goal of treatment will be disease management and improvement in quality of life.
The survival rates for RCC vary according to the stage at diagnosis. Localised RCC has a 5-year survival rate greater than 90%, while the rate drops significantly for metastatic RCC; however, therapies are improving pediatric outcomes.
There are no guaranteed ways to prevent RCC, but reducing risk factors like cessation of smoking, maintaining a healthy body weight, and controlling blood pressure may help decrease the chances of developing the disease.
Side effects of treatment strategies for RCC include surgery, immunotherapy, and targeted therapies; fatigue, nausea, skin rashes, high blood pressure, and increased susceptibility to infections are among them. Discussions with healthcare team members regarding potential side effects can facilitate effective management.
Yes, RCC can still recur even after successful treatment. Continuous monitoring with regular check-ups and imaging tests is necessary to catch any disease recurrence in its early stage so that measures can be taken accordingly.
Yes, leading hospitals are using robotic-assisted and laparoscopic surgeries for RCC. This ensures a precise diagnosis, faster recovery, and fewer complications for the patient.
This varies according to the treatment plan; if the patient is undergoing surgery, the stay may be for a week or two, while those receiving targeted therapy or follow-up care may need more extended visits.

Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026